Calnexin Impairs the Antitumor Immunity of CD4+ and CD8+ T Cells.
Chen Y, Ma D, Wang X, Fang J, Liu X, Song J, Li X, Ren X, Li Q, Li Q, Wen S, Luo L, Xia J, Cui J, Zeng G, Chen L, Cheng B, Wang Z.
Chen Y, et al. Among authors: wang x, wang z.
Cancer Immunol Res. 2019 Jan;7(1):123-135. doi: 10.1158/2326-6066.CIR-18-0124. Epub 2018 Nov 6.
Cancer Immunol Res. 2019.
PMID: 30401678